Furthermore, the injection of anti-CIRP antibodies through the internal jugular vein markedly reduced inflammation and tissue damage in a hepatic ischemia-reperfusion model, thereby improving the viability of mice [37]. This evidence concerns the gene CIRBP and ischemia.